Delivery Order SPE2DR25D9239-SPE2DR26FFBJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL (133 mg/10 mL vial). This firm fixed-price delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency issued a delivery order valued at $5,124.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The award, issued on November 3, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was awarded on October 17, 2025. This award carries no set-aside designation, demonstrating the vendor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $26,113.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the award was made through competitive procurement. The delivery order is issued under DMS...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $9,044.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This delivery order, awarded on October 20, 2025, represents one of numerous pharmaceutical procurement actions issued to the vendor during October 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $5,021.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EXPAREL 266 mg/20 ml vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the vendor competed in an unrestricted federal procurement environment. This award falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $7,536.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and was awarded on September 23, 2025. No set-aside designation was utilized for this award, indicating the vendor competed on an unrestricted...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBJ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, requires no set-aside designation, indicating the awardee competed successfully in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois, and represents a routine pharmaceutical supply requirement for Department of Defense healthcare operations. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The company's IDC, designated SPE2DR and valued at $499,999,999, was recently awarded on November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period plus three optional 30-month periods. As one of multiple regional prime vendor contractors under PPV-G GEN V, DMS Pharmaceutical Group supplies a comprehensive range of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to military healthcare facilities worldwide, with this specific delivery order for EXPAREL representing a specialty surgical pharmaceutical critical to Department of Defense medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/5/25 |